Literature DB >> 18565761

Comparison of HPLC/ESI-FTICR MS versus MALDI-TOF/TOF MS for glycopeptide analysis of a highly glycosylated HIV envelope glycoprotein.

Janet Irungu1, Eden P Go, Ying Zhang, Dilusha S Dalpathado, Hua-Xin Liao, Barton F Haynes, Heather Desaire.   

Abstract

Defining the structures and locations of the glycans attached on secreted proteins and virus envelope proteins is important in understanding how glycosylation affects their biological properties. Glycopeptide mass spectrometry (MS)-based analysis is a very powerful, emerging approach to characterize glycoproteins, in which glycosylation sites and the corresponding glycan structures are elucidated in a single MS experiment. However, to date there is not a consensus regarding which mass spectrometric platform provides the best glycosylation coverage information. Herein, we employ two of the most widely used MS approaches, online high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC/ESI-MS) and offline HPLC followed by matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS), to determine which of the two approaches provides the best glycosylation coverage information of a complex glycoprotein, the group M consensus HIV-1 envelope, CON-S gp140DeltaCFI, which has 31 potential glycosylation sites. Our results highlight differences in the informational content obtained between the two methods such as the overall number of glycosylation sites detected, the numbers of N-linked glycans present at each site, and the type of confirmatory information obtained about the glycopeptide using MS/MS experiments. The two approaches are quite complementary, both in their coverage of glycopeptides and in the information they provide in MS/MS experiments. The information in this study contributes to the field of mass spectrometry by demonstrating the strengths and limitations of two widely used MS platforms in glycoprotein analysis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18565761      PMCID: PMC3706080          DOI: 10.1016/j.jasms.2008.05.010

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  37 in total

1.  Characterization of glycopeptides from HIV-I(SF2) gp120 by liquid chromatography mass spectrometry.

Authors:  Jenny M Cutalo; Leesa J Deterding; Kenneth B Tomer
Journal:  J Am Soc Mass Spectrom       Date:  2004-11       Impact factor: 3.109

2.  Method for characterizing sulfated glycoproteins in a glycosylation site-specific fashion, using ion pairing and tandem mass spectrometry.

Authors:  Janet Irungu; Dilusha S Dalpathado; Eden P Go; Hui Jiang; Hy-Vy Ha; George R Bousfield; Heather Desaire
Journal:  Anal Chem       Date:  2006-02-15       Impact factor: 6.986

3.  A role for carbohydrates in immune evasion in AIDS.

Authors:  J N Reitter; R E Means; R C Desrosiers
Journal:  Nat Med       Date:  1998-06       Impact factor: 53.440

4.  Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation.

Authors:  C Cheng-Mayer; A Brown; J Harouse; P A Luciw; A J Mayer
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

Review 5.  Glycoproteins in prokaryotes.

Authors:  S Moens; J Vanderleyden
Journal:  Arch Microbiol       Date:  1997-09       Impact factor: 2.552

6.  Protein glycosylation analyzed by normal-phase nano-liquid chromatography--mass spectrometry of glycopeptides.

Authors:  Manfred Wuhrer; Carolien A M Koeleman; Cornelis H Hokke; André M Deelder
Journal:  Anal Chem       Date:  2005-02-01       Impact factor: 6.986

Review 7.  Glycomics and mass spectrometry.

Authors:  Willy Morelle; Jean-Claude Michalski
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

8.  An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization.

Authors:  N K Back; L Smit; J J De Jong; W Keulen; M Schutten; J Goudsmit; M Tersmette
Journal:  Virology       Date:  1994-03       Impact factor: 3.616

Review 9.  Glycopeptide analysis by mass spectrometry.

Authors:  Dilusha S Dalpathado; Heather Desaire
Journal:  Analyst       Date:  2008-03-19       Impact factor: 4.616

10.  The antigenic structure of the HIV gp120 envelope glycoprotein.

Authors:  R Wyatt; P D Kwong; E Desjardins; R W Sweet; J Robinson; W A Hendrickson; J G Sodroski
Journal:  Nature       Date:  1998-06-18       Impact factor: 49.962

View more
  38 in total

Review 1.  Mass spectrometry based glycoproteomics--from a proteomics perspective.

Authors:  Sheng Pan; Ru Chen; Ruedi Aebersold; Teresa A Brentnall
Journal:  Mol Cell Proteomics       Date:  2010-08-24       Impact factor: 5.911

Review 2.  Glycomics and glycoproteomics of viruses: Mass spectrometry applications and insights toward structure-function relationships.

Authors:  John F Cipollo; Lisa M Parsons
Journal:  Mass Spectrom Rev       Date:  2020-04-29       Impact factor: 10.946

3.  Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120.

Authors:  Jennifer L Kirchherr; Jennifer Hamilton; Xiaozhi Lu; S Gnanakaran; Mark Muldoon; Marcus Daniels; Webster Kasongo; Victor Chalwe; Chanda Mulenga; Lawrence Mwananyanda; Rosemary M Musonda; Xing Yuan; David C Montefiori; Bette T Korber; Barton F Haynes; Feng Gao
Journal:  Virology       Date:  2010-10-30       Impact factor: 3.616

4.  Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization.

Authors:  James M Binley; Yih-En Andrew Ban; Emma T Crooks; Dirk Eggink; Keiko Osawa; William R Schief; Rogier W Sanders
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

5.  Label-free quantitation: a new glycoproteomics approach.

Authors:  Kathryn R Rebecchi; Jamie L Wenke; Eden P Go; Heather Desaire
Journal:  J Am Soc Mass Spectrom       Date:  2009-03-09       Impact factor: 3.109

6.  Biomarkers of HIV-1-associated neurocognitive disorders: challenges of proteomic approaches.

Authors:  Pawel Ciborowski
Journal:  Biomark Med       Date:  2009-12       Impact factor: 2.851

7.  A classifier based on accurate mass measurements to aid large scale, unbiased glycoproteomics.

Authors:  John W Froehlich; Eric D Dodds; Mathias Wilhelm; Oliver Serang; Judith A Steen; Richard S Lee
Journal:  Mol Cell Proteomics       Date:  2013-02-25       Impact factor: 5.911

8.  Two-dimensional gel-based approaches for the assessment of N-Linked and O-GlcNAc glycosylation in human and simian immunodeficiency viruses.

Authors:  David R M Graham; Megan J Mitsak; Steven T Elliott; Dawn Chen; Stephen A Whelan; Gerald W Hart; Jennifer E Van Eyk
Journal:  Proteomics       Date:  2008-12       Impact factor: 3.984

9.  Carbohydrates and activity of natural and recombinant tissue factor.

Authors:  Jolanta Krudysz-Amblo; Mark E Jennings; Kenneth G Mann; Saulius Butenas
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

10.  Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition.

Authors:  Milan Raska; Kazuo Takahashi; Lydie Czernekova; Katerina Zachova; Stacy Hall; Zina Moldoveanu; Matt C Elliott; Landon Wilson; Rhubell Brown; Dagmar Jancova; Stephen Barnes; Jana Vrbkova; Milan Tomana; Phillip D Smith; Jiri Mestecky; Matthew B Renfrow; Jan Novak
Journal:  J Biol Chem       Date:  2010-05-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.